:: CLDF ::

Hepatitis C virus associated hepatocellular carcinoma

Adv Cancer Res. 2021;149:103-142. doi: 10.1016/bs.acr.2020.10.003. Epub 2020 Nov 16.

Mousumi Khatun¹, Ranjit Ray², Ratna B Ray³

Neutrophil-to-Lymphocyte ratio predicts high risk explant features and waitlist survival but is not independently associated with recurrence or survival following liver transplantation for hepatocellular carcinoma

Liver Transpl. 2021 Feb 11. doi: 10.1002/lt.26010. Online ahead of print.

Emily Harding-Theobald¹, Francis Y Yao^2 3, Neil Mehta²

Extending the use of atezolizumab and bevacizumab to a liver transplant recipient: need for a post-transplant registry

Liver Transpl. 2021 Feb 11. doi: 10.1002/lt.26011. Online ahead of print.

Najib Ben Khaled¹, Daniel Roessler¹, Florian P Reiter¹, Max Seidensticker², Markus Guba³, Enrico N De Toni¹

Caffeinated Coffee Consumption and Health Outcomes in the US Population: A Dose-Response Meta-Analysis and Estimation of Disease Cases and Deaths Avoided

Adv Nutr. 2021 Feb 11;nmaa177. doi: 10.1093/advances/nmaa177. Online ahead of print.

Matteo Di Maso¹, Paolo Boffetta^2 3, Eva Negri⁴, Carlo La Vecchia¹, Francesca Bravi¹

Combined hepatocellular-cholangiocarcinoma: An update

J Hepatol. 2021 Feb 2;S0168-8278(21)00084-2. doi: 10.1016/j.jhep.2021.01.035.Online ahead of print.

Aurélie Beaufrère¹, Julien Calderaro², Valérie Paradis³

End-points in clinical trials for liver cancer and their value in evidence based clinical decision making: an unresolved Gordian knot

J Hepatol. 2021 Feb 1;S0168-8278(21)00082-9. doi: 10.1016/j.jhep.2021.01.033.Online ahead of print.

Jordi Bruix¹

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

Nat Rev Gastroenterol Hepatol. 2021 Jan 28. doi: 10.1038/s41575-020-00395-0.Online ahead of print.

Josep M Llovet^1 2 3, Thierry De Baere^4 5, Laura Kulik⁶, Philipp K Haber⁷, Tim F Greten⁸, Tim Meyer^9 10, Riccardo Lencioni^11 12

End-of-Life Hospice Use and Medicare Expenditures Among Patients Dying of Hepatocellular Carcinoma

Ann Surg Oncol. 2021 Feb 2. doi: 10.1245/s10434-021-09606-7. Online ahead of print.

Daniel R Rice¹, J Madison Hyer¹, Adrian Diaz¹, Timothy M Pawlik²

Hepatocellular carcinoma

Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.

Josep M Llovet^1 2 3, Robin Kate Kelley⁴, Augusto Villanueva⁵, Amit G Singal⁶, Eli Pikarsky⁷, Sasan Roayaie⁸, Riccardo Lencioni^9 10, Kazuhiko Koike¹¹, Jessica Zucman-Rossi^12 13, Richard S Finn¹⁴

10.

Title: Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival

J Viral Hepat. 2021 Jan 22. doi: 10.1111/jvh.13475. Online ahead of print.

Ian Lockart^1 2, Behzad Hajarizadeh³, Maryam Alavi³, Scott Davison^4 5, Emilia Prakoso^4 6, Miriam T Levy^4 5, Jacob George⁷, Gregory J Dore^2 3, Mark Danta^1 2

11.

The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma

Cancers (Basel). 2021 Jan 11;13(2):E238. doi: 10.3390/cancers13020238.

Philippe Merle¹

12.

Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma

Eur J Med Chem. 2021 Jan 5;213:113135. doi: 10.1016/j.ejmech.2020.113135.Online ahead of print.

Anthony A Stephenson¹, Sheng Cao², David J Taggart², Vinod P Vyavahare², Zucai Suo³

13.

We need stronger evidence for (or against) hepatocellular carcinoma surveillance

J Hepatol. 2021 Jan 16;S0168-8278(21)00020-9. doi: 10.1016/j.jhep.2020.12.029.Online ahead of print.

Peter Jepsen¹, Joe West²

14.

Combining Chemistry and Engineering for Hepatocellular Carcinoma: Nano-Scale and Smaller Therapies

Pharmaceutics. 2020 Dec 20;12(12):1243. doi: 10.3390/pharmaceutics12121243.

Danielle L Stolley¹, Anna Colleen Crouch², Aliçan Özkan³, Erin H Seeley⁴, Elizabeth M Whitley², Marissa Nichole Rylander¹, Erik N K Cressman²

15.

Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes

Surg Oncol. 2020 Dec 30;36:138-146. doi: 10.1016/j.suronc.2020.12.011. Online ahead of print.

Phillip M Kemp Bohan¹, Anne E O'Shea¹, Andrew J Lee², Robert C Chick¹, Timothy E Newhook³, Hop S Tran Cao³, Casey J Allen³, Daniel W Nelson⁴, G Travis Clifton¹, Jean-Nicolas Vauthey³, Ching-Wei D Tzeng³, Timothy J Vreeland⁵

16.

The Association between Diet and Hepatocellular Carcinoma: A Systematic Review

Nutrients. 2021 Jan 8;13(1):E172. doi: 10.3390/nu13010172.

Elena S George¹, Surbhi Sood¹, Anna Broughton¹, Georgia Cogan¹, Megan Hickey¹, Wai San Chan¹, Sonal Sudan¹, Amanda J Nicoll²

17.

Namodenoson in Advanced Hepatocellular Carcinoma and Child-Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial

Cancers (Basel). 2021 Jan 7;13(2):E187. doi: 10.3390/cancers13020187.

Salomon M Stemmer¹, Nebojsa S Manojlovic², Mihai Vasile Marinca³, Petar Petrov⁴, Nelly Cherciu⁵, Doina Ganea⁶, Tudor Eliade Ciuleanu⁷, Ioana Adriana Pusca⁸, Muhammad Shaalan Beg⁹, William T Purcell¹⁰, Adina-Emilia Croitoru¹¹, Rumyana Nedyalkova Ilieva¹², Sladjana Natoševic¹³, Amedeia Lavinir Nita¹⁴, Dimitar Nikolaev Kalev¹⁵, Zivit Harpaz¹⁶, Motti Farbstein¹⁶, Michael H Silverman¹⁶, David Bristol¹⁶, Inbal Itzhak¹⁶, Pnina Fishman¹⁶

18.

Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score

J Hepatol. 2021 Jan 13;S0168-8278(21)00004-0. doi: 10.1016/j.jhep.2020.12.021.Online ahead of print.

David Goldberg¹, Alejandro Mantero², Craig Newcomb³, Cindy Delgado⁴, Kimberly A Forde⁵, David E Kaplan⁶, Binu John⁷, Nadine Nuchovich⁴, Barbara Dominguez⁴, Ezekiel Emanuel⁸, Peter P Reese⁹

19.

Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directions

Curr Oncol. 2020 Nov;27(Suppl 3):S152-S164. doi: 10.3747/co.27.7315.Epub 2020 Nov 1.

A Weinmann¹, P R Galle¹

20.

Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver

Eur Radiol. 2021 Jan 6. doi: 10.1007/s00330-020-07559-1. Online ahead of print.

Paula M Oestmann^1 2 3, Clinton J Wang^1 4, Lynn J Savic^1 2, Charlie A Hamm^1 2, Sophie Stark^1 2 5, Isabel Schobert^1 2, Bernhard Gebauer², Todd Schlachter¹, MingDe Lin¹, Jeffrey C Weinreb¹, Ramesh Batra⁶, David Mulligan⁶, Xuchen Zhang⁷, James S Duncan^1 4, Julius Chapiro⁸

21.

Optimizing the Combination of Immunotherapy and Trans-Arterial Locoregional Therapy for Stages B and C Hepatocellular Cancer

Ann Surg Oncol. 2021 Jan 3. doi: 10.1245/s10434-020-09414-5.Online ahead of print.

Matthew R Woeste^1 2, Anne E Geller^1 2, Robert C G Martin 2nd³, Hiram C Polk Jr¹

22.

Travel distance and overall survival in hepatocellular cancer care

Am J Surg. 2020 Dec 31;S0002-9610(20)30830-8. doi: 10.1016/j.amjsurg.2020.12.052.Online ahead of print.

Julie B Siegel¹, Shelby Allen², Kathryn E Engelhardt³, Katherine A Morgan¹, William P Lancaster⁴

23.

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline

J Clin Oncol. 2020 Dec 20;38(36):4317-4345. doi: 10.1200/JCO.20.02672. Epub 2020 Nov 16.

John D Gordan¹, Erin B Kennedy², Ghassan K Abou-Alfa³, Muhammad Shaalan Beg⁴, Steven T Brower⁵, Terence P Gade⁶, Laura Goff⁷, Shilpi Gupta⁸, Jennifer Guy⁹, William P Harris¹⁰, Renuka Iyer¹¹, Ishmael Jaiyesimi¹², Minaxi Jhawer¹³, Asha Karippot¹⁴, Ahmed O Kaseb¹⁵, R Kate Kelley¹, Jennifer J Knox¹⁶, Jeremy Kortmansky¹⁷, Andrea Leaf¹⁸, William M Remak¹⁹, Rachna T Shroff²⁰, Davendra P S Sohal²¹, Tamar H Taddei²², Neeta K Venepalli²³, Andrea Wilson²⁴, Andrew X Zhu²⁵, Michal G Rose²⁶

24.

Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI

Hepatoma Res. 2020;6:59. doi: 10.20517/2394-5079.2020.50. Epub 2020 Sep 1.

Ryan L Brunsing¹, Kathryn J Fowler², Takeshi Yokoo³, Guilherme Moura Cunha², Claude B Sirlin², Robert M Marks^4 5

25.

Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C

Transplant Direct. 2020 Dec 8;7(1):e635. doi: 10.1097/TXD.0000000000001049.eCollection 2021 Jan.

Chung Sang Tse^1 2, Ju Dong Yang^3 4 5, Omar Y Mousa^6 7, Kevin M Nelson⁶, Surakit Pungpapong⁷, Andrew Keaveny⁷, Bashar A Aqel⁸, Hugo Vargas⁸, Rolland C Dickson⁸, Kymberly Watt⁶, Gregory J Gores⁶, Lewis R Roberts⁶, Michael D Leise⁶

HCC Innovations